Premium
Characterization of Immune Responses Following Intranasal Immunization with the Mycobacterium bovis CFP‐10 Protein Expressed by Attenuated Salmonella typhimurium
Author(s) -
Zhang H.,
Wen K.,
Shen J.,
Geng S.,
Huang J.,
Pan Z.,
Jiao X.
Publication year - 2010
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.2010.02421.x
Subject(s) - mycobacterium bovis , immune system , immunization , salmonella , nasal administration , immunity , microbiology and biotechnology , antigen , biology , immunology , spleen , mycobacterium tuberculosis , tuberculosis , virology , medicine , bacteria , pathology , genetics
Culture filtrate protein 10 (CFP‐10) from Mycobacterium bovis or Mycobacterium tuberculosis (MTB) is an immunodominant T‐cell antigen expressed during the early stages of infection. Because lungs are most commonly associated with primary M. bovis infections, specific immunity at this site is desirable for protection. Therefore, in this study, immune responses generated in mouse lung, spleen and Peyer’s patches were examined following intranasal (i.n.) immunization with Salmonella typhimurium – expressing CFP‐10. Cells harvested from the lungs and Peyer’s patches of immunized mice and then stimulated with CFP‐10 produced significant levels of IFN‐γ and these mice developed elevated serum IgG and lung IgA anti‐CFP‐10 responses, suggesting that this approach induced potent anti‐CFP‐10 mucosal immunity. Our study demonstrates that i.n. administration of CFP‐10 expressed by S. typhimurium represents an effective way to induce efficient immune response to M. bovis antigen.